Pfizer said Tuesday that its antiviral COVID-19 medication is highly effective at preventing severe illness causing hospitalization or death.

“Emerging variants of concern, like Omicron, have exacerbated the need for accessible treatment options for those who contract the virus, and we are confident that, if authorized or approved, this potential treatment could be a critical tool to help quell the pandemic,” Pfizer CEO Albert Bourla said.